Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Direct pericyte-to-neuron reprogramming via unfolding of a neural stem cell-like program.

Karow M, Camp JG, Falk S, Gerber T, Pataskar A, Gac-Santel M, Kageyama J, Brazovskaja A, Garding A, Fan W, Riedemann T, Casamassa A, Smiyakin A, Schichor C, Götz M, Tiwari VK, Treutlein B, Berninger B.

Nat Neurosci. 2018 Jul;21(7):932-940. doi: 10.1038/s41593-018-0168-3. Epub 2018 Jun 18.

PMID:
29915193
2.

ShinyCortex: Exploring Single-Cell Transcriptome Data From the Developing Human Cortex.

Kageyama J, Wollny D, Treutlein B, Camp JG.

Front Neurosci. 2018 May 15;12:315. doi: 10.3389/fnins.2018.00315. eCollection 2018.

3.

Multilineage communication regulates human liver bud development from pluripotency.

Camp JG, Sekine K, Gerber T, Loeffler-Wirth H, Binder H, Gac M, Kanton S, Kageyama J, Damm G, Seehofer D, Belicova L, Bickle M, Barsacchi R, Okuda R, Yoshizawa E, Kimura M, Ayabe H, Taniguchi H, Takebe T, Treutlein B.

Nature. 2017 Jun 22;546(7659):533-538. doi: 10.1038/nature22796. Epub 2017 Jun 14.

PMID:
28614297
4.

Hyperosmotic stress memory in Arabidopsis is mediated by distinct epigenetically labile sites in the genome and is restricted in the male germline by DNA glycosylase activity.

Wibowo A, Becker C, Marconi G, Durr J, Price J, Hagmann J, Papareddy R, Putra H, Kageyama J, Becker J, Weigel D, Gutierrez-Marcos J.

Elife. 2016 May 31;5. pii: e13546. doi: 10.7554/eLife.13546.

5.

Pilot study using mobile health to coordinate the diabetic patient, diabetologist, and ophthalmologist.

Tsui I, Drexler A, Stanton AL, Kageyama J, Ngo E, Straatsma BR.

J Diabetes Sci Technol. 2014 Jul;8(4):845-9. doi: 10.1177/1932296814529637. Epub 2014 Apr 14.

6.

Binding pocket optimization by computational protein design.

Malisi C, Schumann M, Toussaint NC, Kageyama J, Kohlbacher O, Höcker B.

PLoS One. 2012;7(12):e52505. doi: 10.1371/journal.pone.0052505. Epub 2012 Dec 27.

7.

Filicide and fatal abuse in Japan, 1994-2005: temporal trends and regional distribution.

Yasumi K, Kageyama J.

J Forensic Leg Med. 2009 Feb;16(2):70-5. doi: 10.1016/j.jflm.2008.07.007. Epub 2008 Oct 30.

PMID:
19135001
8.

Cholestatic jaundice: an unusual symptom of isolated adrenocorticotropin deficiency in adults.

Otsuka F, Yamamoto K, Shimada N, Kageyama J, Ogura T, Makino H.

J Endocrinol Invest. 2004 Apr;27(4):404-5. No abstract available.

PMID:
15233564
9.

Ciliated foregut cyst of the gallbladder: report of a case.

Muraoka A, Watanabe N, Ikeda Y, Kokudo Y, Tatemoto A, Sone Y, Kagawa S, Tsumura M, Tsuruno M, Kageyama J, Kojima K, Mizobuchi K.

Surg Today. 2003;33(9):718-21.

PMID:
12928855
10.

Aphakic hydrogel contact lens fitting on a monocular canine: a case report.

Yeung KK, Silverman BS, Kageyama JY.

Optometry. 2001 Jul;72(7):421-5.

PMID:
11486936
11.

Cluster headache dependent upon octreotide injection.

Otsuka F, Kageyama J, Ogura T, Makino H.

Headache. 1998 Sep;38(8):629. No abstract available.

PMID:
11398310
12.

The nature and diurnal variation of criminal acts committed by patients with mood disorders.

Kageyama J, Ishii T, Hasegawa N, Saito K, Kusaka K.

Int J Law Psychiatry. 2000 Jan-Feb;23(1):53-9. No abstract available.

PMID:
10730209
13.
14.

Chronic treatment with angiotensin II type 1 receptor antagonist suppresses glomerular activator protein-1 activity in salt-sensitive hypertensive rats.

Otsuka F, Ogura T, Yamauchi T, Sato M, Kataoka H, Kageyama J, Makino H.

Kidney Blood Press Res. 2000;23(1):35-41.

15.

Pharmacologically stimulated portal flow measurement by magnetic resonance imaging for assessment of liver function.

Nakano S, Katoh T, Ohki M, Mori Y, Kageyama J, Toyama Y, Hino I, Satoh K, Ohkawa M.

Radiat Med. 1999 Jan-Feb;17(1):21-6.

PMID:
10378648
16.

Long-term administration of adrenocorticotropin modulates the expression of IGF-I and TGF-beta 1 mRNAs in the rat adrenal cortex.

Otsuka F, Ogura T, Yamauchi T, Kataoka H, Kishida M, Miyatake N, Mimura Y, Kageyama J, Makino H.

Growth Horm IGF Res. 1999 Feb;9(1):41-51.

PMID:
10207507
17.

Sheehan's syndrome of more than 30 years' duration: an endocrine and MRI study of 6 cases.

Otsuka F, Kageyama J, Ogura T, Hattori T, Makino H.

Endocr J. 1998 Aug;45(4):451-8. Review.

18.

Renal c-fos expression induced by angiotensin II is enhanced in spontaneously hypertensive rats.

Otsuka F, Yamauchi T, Ogura T, Takahashi M, Kageyama J, Makino H.

Life Sci. 1998;63(23):2089-95.

PMID:
9839532
19.

Pituitary apoplexy induced by a combined anterior pituitary test: case report and literature review.

Otsuka F, Kageyama J, Ogura T, Makino H.

Endocr J. 1998 Jun;45(3):393-8. Review.

20.

Reversible hypothyroidism in empty sella syndrome: a case report.

Otsuka F, Ogura T, Hayakawa N, Harada S, Kageyama J, Makino H.

Endocr J. 1998 Jun;45(3):385-91.

21.

[MRI phase contrast flow measurement of portal vein: influence and compensation of respiratory motion and propriety of phase correction using background].

Nakano S, Katoh T, Wakimaru K, Mori Y, Kageyama J, Hino I, Satoh K, Ohkawa M.

Nihon Igaku Hoshasen Gakkai Zasshi. 1998 Aug;58(9):489-96. Japanese.

PMID:
9778934
22.

Manifestation of primary hyperthyroidism after pituitary adenomectomy: a case report.

Otsuka F, Ogura T, Hayakawa N, Mimura Y, Kageyama J, Makino H.

Endocr J. 1997 Dec;44(6):887-93.

23.

IDDM accompanied by a growth hormone-producing pituitary adenoma. A case report.

Otsuka F, Ogura T, Yamauchi T, Shikata K, Kageyama J, Makino H.

Diabetes Care. 1997 Dec;20(12):1838-41.

PMID:
9405903
24.

A case of primary hyperparathyroidism accompanying multiple myeloma.

Otsuka F, Hayakawa N, Ogura T, Kataoka H, Kawashima M, Mimura Y, Yamauchi T, Kashihara N, Kageyama J, Makino H.

Endocr J. 1997 Feb;44(1):105-9. Review.

25.

[Alcohol crime].

Kageyama J.

Nihon Rinsho. 1997 Feb;55 Suppl:559-65. Review. Japanese. No abstract available.

PMID:
9078788
26.

A case of Schmidt syndrome accompanied by a pituitary adenoma.

Otsuka F, Ogura T, Hayakawa N, Hashimoto M, Makino H, Ota Z, Kageyama J.

Endocr J. 1996 Oct;43(5):495-502.

27.

A patient with sarcoidosis associated with recurrent urolithiasis and tubular injury caused by calcium deposition.

Mimura Y, Maeshima Y, Ogura T, Kashihara N, Kawabata K, Hayakawa N, Nagake Y, Hironaka K, Makino H, Ota Z, Kageyama J.

Nihon Jinzo Gakkai Shi. 1996 Mar;38(3):141-5.

PMID:
8721336
28.

Developmental change of kidney dopamine receptors in spontaneously hypertensive rats.

Watanabe H, Ogura T, Hosoya M, Kageyama J, Ota Z.

Res Commun Mol Pathol Pharmacol. 1995 Mar;87(3):333-44.

PMID:
7620826
29.

Enhanced pressor response in spontaneously hypertensive rats induced by stimulation of vasopressin-V1 receptors.

Yamauchi T, Ogura T, Oishi T, Harada K, Hashimoto M, Mimura Y, Asano N, Ota Z, Kageyama J.

Acta Med Okayama. 1995 Feb;49(1):53-9.

PMID:
7762410
30.

Crohn's disease associated with growth hormone secretory dysfunction.

Ogura T, Kageyama J, Itano Y, Yamauchi T, Oishi T, Aita T, Hayakawa N, Ogasa T, Ota K, Ota Z, et al.

Intern Med. 1995 Feb;34(2):112-7.

31.

Plasma levels of corticotropin-releasing hormone in hypothalamic-pituitary-adrenal disorders and chronic renal failure.

Hashimoto K, Nishioka T, Numata Y, Ogasa T, Kageyama J, Suemaru S.

Acta Endocrinol (Copenh). 1993 Jun;128(6):503-7.

PMID:
8393256
32.

Cerebrospinal fluid corticotropin-releasing hormone and ACTH, and peripherally circulating choline-containing phospholipid in senile dementia.

Suemaru S, Suemaru K, Hashimoto K, Ogasa T, Hirasawa R, Makino S, Kageyama J.

Life Sci. 1993;53(9):697-706.

PMID:
8394971
34.

A case of non-Hodgkin's lymphoma associated with hypercalcemia.

Suemaru S, Kageyama J, Ota Z, Ohnoshi T, Sakamoto K, Kamura J.

Acta Med Okayama. 1991 Feb;45(1):55-9.

PMID:
2063696
35.

Cerebrospinal fluid and plasma corticotropin-releasing hormone in senile dementia.

Suemaru S, Hashimoto K, Ogasa T, Hirasawa R, Makino S, Ota Z, Kageyama J, Suemaru K.

Life Sci. 1991;48(19):1871-9.

PMID:
1645837
36.

Central interaction between endothelin and brain natriuretic peptide on pressor and hormonal responses.

Makino S, Hashimoto K, Hirasawa R, Hattori T, Kageyama J, Ota Z.

Brain Res. 1990 Nov 26;534(1-2):117-21.

PMID:
1963557
37.

[Perfusion study of the pulmonary hilar region by SPECT--normal cases].

Satoh K, Tanabe M, Kawase Y, Kawasaki Y, Matsuno S, Hosokawa N, Yoden M, Kageyama J, Tsuuchi Y, Toyama Y.

Radioisotopes. 1990 Oct;39(10):439-44. Japanese.

PMID:
2247657
38.

Effect of hypertonic saline on the corticotropin-releasing hormone and arginine vasopressin content of the rat pituitary neurointermediate lobe.

Hashimoto K, Suemaru S, Hirasawa R, Takao T, Makino S, Kageyama J, Ogasa T, Ota Z, Kawata M.

Endocrinol Jpn. 1990 Oct;37(5):599-606.

39.

Combined anterior pituitary function test using CRH, GRH, LH-RH, TRH and vasopressin in patients with non-functioning pituitary tumors.

Hashimoto K, Makino S, Hirasawa R, Takao T, Kageyama J, Ogasa T, Ota Z.

Acta Med Okayama. 1990 Jun;44(3):141-7.

PMID:
2200236
40.

[Pulmonary lesion of paraquat poisoning on high resolution CT].

Kageyama J, Satoh K, Kawase Y, Kojima K, Tamai T, Ohkawa M, Tanabe M, Shirakawa Y, Oguri K.

Kokyu To Junkan. 1990 Mar;38(3):273-6. Japanese.

PMID:
2330462
41.

Synthetic analogs of growth hormone-releasing factor with antagonistic activity in vitro.

Sato K, Hotta M, Kageyama J, Hu HY, Dong MH, Ling N.

Biochem Biophys Res Commun. 1990 Feb 28;167(1):360-6.

PMID:
2106886
42.

Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.

Hashimoto K, Suemaru S, Takao T, Sugawara M, Hattori T, Kageyama J, Takahashi K, Ota Z.

J Clin Invest. 1988 Jul;82(1):13-6.

43.

Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted with a single D-amino acid.

Sato K, Hotta M, Kageyama J, Chiang TC, Hu HY, Dong MH, Ling N.

Biochem Biophys Res Commun. 1987 Dec 16;149(2):531-7.

PMID:
3122736
44.

Dual effects of (D-Ala2,Met5)-enkephalinamide on CRF and ACTH secretion.

Hashimoto K, Suemaru S, Ono N, Hattori T, Inoue H, Takao T, Sugawara M, Kageyama J, Ota Z.

Peptides. 1987 Jan-Feb;8(1):113-8.

PMID:
3033617
45.

[A case of a simple virilizing form of 21-hydroxylase deficiency with schizophrenic symptoms, marked pigmentation and highly elevated plasma deoxycorticosterone].

Suemaru S, Hashimoto K, Hattori T, Inoue H, Kageyama J, Ota Z.

Nihon Naika Gakkai Zasshi. 1987 Jan;76(1):112-7. Japanese. No abstract available.

PMID:
3033104
46.
47.

Effects of (D-ala2, met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion.

Hashimoto K, Suemaru S, Hattori T, Takao T, Inoue H, Sugawara M, Kageyama J, Ota Z.

Endocrinol Jpn. 1986 Dec;33(6):813-20.

48.

Effect of synthetic atrial natriuretic polypeptide on hemorrhage-induced adrenocorticotropin secretion of the rat.

Hattori T, Hashimoto K, Inoue H, Sugawara M, Suemaru S, Kageyama J, Ota Z.

Endocrinol Jpn. 1986 Oct;33(5):533-9.

49.

Starvation-induced changes in rat brain corticotropin-releasing factor (CRF) and pituitary-adrenocortical response.

Suemaru S, Hashimoto K, Hattori T, Inoue H, Kageyama J, Ota Z.

Life Sci. 1986 Sep 29;39(13):1161-6.

PMID:
3018413
50.

Cortisol responsiveness to insulin-induced hypoglycemia in Cushing's syndrome with huge nodular adrenocortical hyperplasia.

Hashimoto K, Kawada Y, Murakami K, Hattori T, Suemaru S, Kageyama J, Ota Z, Hayata S, Ohashi T, Omori H.

Endocrinol Jpn. 1986 Aug;33(4):479-87.

Supplemental Content

Loading ...
Support Center